Kalaris Therapeutics, Inc. (KLRS)
4.08
-0.07
(-1.69%)
USD |
NASDAQ |
Aug 24, 16:00
4.08
0.00 (0.00%)
After-Hours: 20:00
Kalaris Therapeutics Total Assets (Quarterly) : 99.54M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 99.54M |
| March 31, 2026 | 109.80M |
| December 31, 2025 | 121.74M |
| September 30, 2025 | 81.18M |
| June 30, 2025 | 92.84M |
| March 31, 2025 | 103.09M |
| December 31, 2024 | 6.162M |
| September 30, 2024 | 122.53M |
| June 30, 2024 | 130.99M |
| March 31, 2024 | 144.14M |
| December 31, 2023 | 190.80M |
| September 30, 2023 | 248.31M |
| June 30, 2023 | 282.69M |
| March 31, 2023 | 244.04M |
| Date | Value |
|---|---|
| December 31, 2022 | 277.08M |
| September 30, 2022 | 293.70M |
| June 30, 2022 | 200.00M |
| March 31, 2022 | 231.09M |
| December 31, 2021 | 286.59M |
| September 30, 2021 | 316.53M |
| June 30, 2021 | 327.51M |
| March 31, 2021 | 351.28M |
| December 31, 2020 | 370.82M |
| September 30, 2020 | 393.71M |
| June 30, 2020 | 117.85M |
| March 31, 2020 | 128.69M |
| December 31, 2019 | 139.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Replimune Group, Inc. | 252.45M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 41.87M |
| Shareholders Equity (Quarterly) | 57.67M |
| Debt to Equity Ratio | 0.0243 |
| Current Ratio | 10.92 |
| Net Debt Paydown Yield | -0.29% |